chr2-197393071-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1
The NM_012433.4(SF3B1):āc.3657A>Gā(p.Val1219=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.679 in 1,611,676 control chromosomes in the GnomAD database, including 375,213 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.71 ( 39045 hom., cov: 32)
Exomes š: 0.68 ( 336168 hom. )
Consequence
SF3B1
NM_012433.4 synonymous
NM_012433.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.231
Genes affected
SF3B1 (HGNC:10768): (splicing factor 3b subunit 1) This gene encodes subunit 1 of the splicing factor 3b protein complex. Splicing factor 3b, together with splicing factor 3a and a 12S RNA unit, forms the U2 small nuclear ribonucleoproteins complex (U2 snRNP). The splicing factor 3b/3a complex binds pre-mRNA upstream of the intron's branch site in a sequence independent manner and may anchor the U2 snRNP to the pre-mRNA. Splicing factor 3b is also a component of the minor U12-type spliceosome. The carboxy-terminal two-thirds of subunit 1 have 22 non-identical, tandem HEAT repeats that form rod-like, helical structures. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.46).
BP6
Variant 2-197393071-T-C is Benign according to our data. Variant chr2-197393071-T-C is described in ClinVar as [Benign]. Clinvar id is 1250652.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-197393071-T-C is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.231 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.829 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SF3B1 | NM_012433.4 | c.3657A>G | p.Val1219= | synonymous_variant | 24/25 | ENST00000335508.11 | |
SF3B1 | XM_047443838.1 | c.3219A>G | p.Val1073= | synonymous_variant | 21/22 | ||
SF3B1 | XM_047443839.1 | c.3219A>G | p.Val1073= | synonymous_variant | 21/22 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SF3B1 | ENST00000335508.11 | c.3657A>G | p.Val1219= | synonymous_variant | 24/25 | 1 | NM_012433.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.710 AC: 107863AN: 151992Hom.: 39007 Cov.: 32
GnomAD3 genomes
AF:
AC:
107863
AN:
151992
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.658 AC: 165437AN: 251276Hom.: 56094 AF XY: 0.670 AC XY: 90958AN XY: 135820
GnomAD3 exomes
AF:
AC:
165437
AN:
251276
Hom.:
AF XY:
AC XY:
90958
AN XY:
135820
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.676 AC: 986242AN: 1459566Hom.: 336168 Cov.: 36 AF XY: 0.679 AC XY: 493024AN XY: 726240
GnomAD4 exome
AF:
AC:
986242
AN:
1459566
Hom.:
Cov.:
36
AF XY:
AC XY:
493024
AN XY:
726240
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.710 AC: 107954AN: 152110Hom.: 39045 Cov.: 32 AF XY: 0.706 AC XY: 52531AN XY: 74354
GnomAD4 genome
AF:
AC:
107954
AN:
152110
Hom.:
Cov.:
32
AF XY:
AC XY:
52531
AN XY:
74354
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2280
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 05, 2019 | - - |
SF3B1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 17, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at